Edition:
United States

Fennec Pharmaceuticals Inc (FENC.OQ)

FENC.OQ on NASDAQ Stock Exchange Capital Market

6.05USD
3:59pm EST
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$6.05
Open
$6.11
Day's High
$6.52
Day's Low
$6.00
Volume
17,374
Avg. Vol
16,774
52-wk High
$14.85
52-wk Low
$5.87

Chart for

About

Fennec Pharmaceuticals Inc., formerly Adherex Technologies Inc., is a biopharmaceutical company focused on cancer therapeutics. The Company's lead product candidate in the clinical stage of development includes Sodium Thiosulfate (STS), which has completed patient enrollment of over two Phase III clinical trials for the... (more)
No analyst recommendations are available for .

Overall

Beta: 0.20
Market Cap(Mil.): $168.88
Shares Outstanding(Mil.): 19.10
Dividend: --
Yield (%): --

Financials

  FENC.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -0.68 -- --
ROI: -57.98 0.60 13.80
ROE: -57.98 -2.18 15.29

Earnings vs. Estimates

No consensus analysis data available.